UroGen Pharma (URGN) Non-Current Assets (2016 - 2026)
UroGen Pharma's Non-Current Assets came in at $17.16 million for Q2 2026, up 44.9% from $11.85 million a year earlier and up 5.8% from the prior quarter.
UroGen Pharma (URGN) Non-Current Assets (2016 - 2026) Analysis & Trends
At the end of FY2025, UroGen Pharma's Non-Current Assets was $14.43 million, up 50.7% from FY2024.
- Non-Current Assets has increased in each of the last four years, with a five-year compound annual growth rate of 17.7% (FY2020 to FY2025).
- Going back by year, Non-Current Assets was $9.58 million in FY2024 (+4.9%), $9.13 million in FY2023 (+36.0%), $6.71 million in FY2022 (+25.3%) and $5.36 million in FY2021 (-16.1%).
- The Q2 2026 figure represents the highest quarterly Non-Current Assets since Q2 2020.
- Year-over-year, Non-Current Assets has increased for seven consecutive quarters, with growth averaging 92.7% over the last eight quarters.
- The fastest year-over-year change in Non-Current Assets over five years came in Q2 2025 (growth of 311.3%), and the weakest in Q2 2024 (a decline of 79.5%).
- Business Quant data shows URGN's Non-Current Assets at $16.23 million (Q1 2026), $14.43 million (Q4 2025) and $16.5 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 159.77 Bn |
| 10 | UroGen Pharma | 1.78 Bn | 1.29 Bn | 65.88 Mn | 17.16 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.16 Mn |
| Mar 31, 2026 | 16.23 Mn |
| Dec 31, 2025 | 14.43 Mn |
| Sep 30, 2025 | 16.50 Mn |
| Jun 30, 2025 | 11.85 Mn |
| Mar 31, 2025 | 10.44 Mn |
| Dec 31, 2024 | 9.58 Mn |
| Sep 30, 2024 | 6.85 Mn |
| Jun 30, 2024 | 2.88 Mn |
| Mar 31, 2024 | 3.81 Mn |
| Dec 31, 2023 | 9.13 Mn |
| Sep 30, 2023 | 11.51 Mn |
| Jun 30, 2023 | 14.03 Mn |
| Mar 31, 2023 | 16.98 Mn |
| Dec 31, 2022 | 6.71 Mn |
| Sep 30, 2022 | 6.88 Mn |
| Jun 30, 2022 | 6.52 Mn |
| Mar 31, 2022 | 5.19 Mn |
| Dec 31, 2021 | 5.36 Mn |
| Sep 30, 2021 | 9.46 Mn |
UroGen Pharma Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=URGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();